Home Kangkang Blood Pressure and Taikang Online Launch China's First Consumer-Oriented Hypertension Insurance Product

Kangkang Blood Pressure and Taikang Online Launch China's First Consumer-Oriented Hypertension Insurance Product

Nov 01, 2016 14:14 CST Updated 14:14

On November 1, 2016, Kangkang Blood Pressure partnered with Taikang Online and Kangfu Zhijia (Dekai Pharmaceutical) to launch China’s first consumable insurance product for chronic hypertension management—the Kang³ Hypertension Comprehensive Service Package. The package includes a Kangkang smart blood pressure monitor, VIP services from the Hypertension Steward, pharmaceutical purchase vouchers worth RMB 1,000–1,500, and coverage for four types of hypertension-related complications, with a maximum benefit of RMB 30,000.


Kang Kang Blood Pressure is one of the first key partners in the “Searching for China’s New Medical Insurance Policies” campaign, launched on August 18 this year through a collaboration between Taikang Online, a wholly-owned subsidiary of Taikang Group, and VCBeat (WeChat ID: vcbeat). This product represents a hallmark achievement of their partnership and will help Kang Kang Blood Pressure build a comprehensive hypertension ecosystem.


Product Usage Scenarios


Upon purchasing the product, users will receive a complimentary smart blood pressure monitor valued at RMB 399 and gain access to a hypertension VIP management service valued at RMB 199. This enables early detection and prevention of hypertension. In case of any abnormalities, users can enjoy one-on-one consultations with hypertension specialists and receive medication guidance through the “Hypertension Steward” WeChat Official Account.


Users who need medications can simply upload their prescriptions from home to purchase prescription drugs listed in the hypertension medication catalog. They are eligible for a medication voucher worth up to RMB 1,500, which can be used on the Dekai Pharmacy Mall platform. Notably, users who purchase this product will receive an insurance payout of up to RMB 30,000 if they develop any of the following four hypertension-related conditions: chronic renal failure with uremia, sequelae of stroke, thoracic aortic dissection, or hypertensive heart transplantation.


Currently, this comprehensive hypertension care package, valued at RMB 6,000, is available for pre-order at RMB 939 through Kangfu Zhijia and the De Kai Pharmacy online store.


Multiple Innovative Highlights


The Hypertension Comprehensive Service Package is not merely a promotional product; it encompasses multiple innovative highlights:


1. This is the first comprehensive hypertension insurance product available for purchase in China. In the past, many chronic disease management companies announced collaborations with insurers, aiming to establish a “chronic disease management + financial insurance” model, but no concrete, purchasable products had been launched to date. The comprehensive insurance product jointly introduced by KangKang and Taikang Online is the first collaborative offering in the field of hypertension in China.


2. This is a comprehensive product that integrates smart hardware, commonly used antihypertensive medications, chronic disease management, and insurance services. The KangKang Blood Pressure Program leverages an internet hospital for chronic diseases to address patients’ needs for follow-up consultations. Currently, the product’s medication portfolio includes three commonly prescribed drugs. Zhang Shengming, Director of Innovative Business overseeing this project, stated that the drug variety will be continuously expanded in the near future, with plans to increase the formulary to 20 medications by the first half of next year.


3. This product essentially meets all the needs of users with hypertension. On one hand, it combines precision medication for hypertension and prevention of hypertensive complications through genetic testing, while intelligent blood pressure monitors and VIP services from a hypertension management platform complete user blood pressure monitoring and provide guidance on medical consultations and medication. On the other hand, drug purchase vouchers and medical services help improve users' medication adherence, thereby enabling effective disease control. Once patients develop complications, the associated medical costs can be covered by insurance. As a result, patients can manage their condition daily without leaving home, forming a complete closed-loop system for chronic hypertension management.


4. This is a product that creates a win-win situation for all parties involved. ForInsurance CompanyFrom this perspective, the hypertension management ecosystem reduces the likelihood of users developing complications, thereby laying the foundation for insurers to control costs and tap into the insurance market for the hypertensive population. ForPharmaceutical CompaniesIn general, improved medication adherence and compliance with medical advice can increase drug sales by more than 30%. ForRehabilitation Home (De Kai Pharmacy Online Mall), it serves as an ideal traffic-driving strategy, effectively enhancing the e-commerce platform’s visibility and user engagement. ForUserTo spend the least amount of money on the best products while reducing the risk of hypertensive complications. AndKangkangIt has also ushered in a new strategic layout in the insurance sector, dedicated to perfecting the hypertension ecosystem, achieving a win-win outcome for all stakeholders.


Aspiring to Be an Industry Leader


The launch of this product helped Kangkang Blood Pressure improve itsComplete Closed-Loop Management of Hypertension as a Chronic Disease.On VCBeat (WeChat ID: vcbeat) “Kang Kang Blood Pressure: From Smart Hardware to an Internet Hospital for Chronic Diseases, Securing Nearly RMB 100 Million in Funding Over Three YearsIn the article, Zeng Mingfa, Chairman of Kangkang Blood Pressure, stated that Kangkang Blood Pressure has used smart hardware as an entry point and its chronic disease internet hospital as a strategic pivot. Through continuous exploration, the company has gradually established an end-to-end management process for hypertension and other chronic diseases, encompassing health education and prevention, monitoring with big data analytics, evaluation of pharmaceutical efficacy, chronic disease internet hospital services, and financial insurance solutions, with the ambition to become an industry leader.